| Stage | HNI | % of rev | MLKN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.6B | 100.00% | $923M | 100.00% | HNI ×1.73 |
| Gross profit | $679M | 42.60% | $385M | 41.73% | HNI +0.9pp |
| Operating income | $137M | 8.58% | $52M | 5.61% | HNI +3.0pp |
| Pre-tax income | $121M | 7.62% | $35M | 3.81% | HNI +3.8pp |
| Net income | $90M | 5.65% | $28M | 2.99% | HNI +2.7pp |
| Stage | HNI | MLKN | Gap · A − B |
|---|---|---|---|
| Revenue | $1.6B100.00% | $923M100.00% | HNI ×1.73 |
| Gross profit | 42.60%$679M | 41.73%$385M | HNI +0.9pp |
| Operating income | 8.58%$137M | 5.61%$52M | HNI +3.0pp |
| Pre-tax income | 7.62%$121M | 3.81%$35M | HNI +3.8pp |
| Net income |
| 5.65%$90M |
| 2.99%$28M |
| HNI +2.7pp |
No disclosed counterparties: MLKN.
None